SCHEMBL1114154

SCHEMBL1114154

IC1CCOC(c2n[nH]c3ccccc23)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ PDPK1 O15530 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPK10 P53779 2/20 0.35
▸ IDO1 P14902 2/20 0.35
▸ ALPL P05186 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TTK P33981 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ HTR2A P28223 2/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ LRRK2 Q5S007 5/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPK8 P45983 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5562287 0.80 KDM4E (0.41) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL30540792 0.78 RAB9A (0.42) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL31295238 0.74 DRD2 (0.52) KDM4EGAAPDPK1CYP3A4HTR2A
SCHEMBL3057752 0.70 KDM4E (0.50) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL30619334 0.70 KDM4E (0.43) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL6745979 0.70 KDM4E (0.43) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL5562284 0.68 KDM4E (0.41) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL15485748 0.67 KDM4E (0.47) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL4004747 0.67 RAB9A (0.48) KDM4EGAAPDPK1CYP3A4ALDH1A1
SCHEMBL31295104 0.67 CNR2 (0.48) CYP3A4DRD2CYP1A2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890698-A1 DIOXINO- AND OXAZIN-[2,3-D]PYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2015-07-08 — — EP disclosed
WO-2014033196-A1 DIOXINO- AND OXAZIN-[2,3-D]PYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2014-03-06 — — WO disclosed
EP-2651951-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2013-10-23 — — EP disclosed
WO-2012082997-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA-ROCHE AG (CH) 2012-06-21 — — WO disclosed
EP-2279188-A1 PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2011-02-02 — — EP disclosed
EP-2252616-A1 PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2010-11-24 — — EP disclosed
EP-2207781-A1 THIAZOLOPYRIMIDINE P13K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2010-07-21 — — EP disclosed
WO-2009146406-A1 PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2009-12-03 — — WO disclosed
WO-2009097446-A1 PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2009-08-06 — — WO disclosed
EP-2046799-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Genentech, Inc. (US) 2009-04-15 — — EP disclosed
WO-2009042607-A1 THIAZOLOPYRIMIDINE P13K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2009-04-02 — — WO disclosed
WO-2007127183-A1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GENENTECH, INC. (US) 2007-11-08 — — WO disclosed
Send feedback